Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Zhejiang Ruitong Biotechnology is a specialized molecular diagnostics company based in Hangzhou, China, focusing on the development of next-generation sequencing (NGS) solutions for precision medicine. The company provides an integrated sample-to-report workflow, featuring automated library preparation instruments and high-sensitivity diagnostic reagents. Their product portfolio primarily targets oncology, reproductive health, and infectious disease testing, aiming to standardize complex genomic analysis for clinical use. Ruitong Biotechnology leverages proprietary biochemical technologies to improve the efficiency and accuracy of genetic testing in hospital and laboratory settings. The company is recognized as a high-tech enterprise and maintains rigorous quality standards through ISO 13485 and GMP certifications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Zhejiang Ruitong Biotechnology.